{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Within blocks of Dr. Max Van Gilder's bustling pediatric office near Central Park in Manhattan, patients and their parents can readily find bubble bath from France, chocolates from Belgium and fresh melon from South America. But for months now, Dr. Van Gilder's youngest patients have had to wait for their shots against diseases like measles and diphtheria and to come back to his office once they were available. ''I never know on a given day which vaccines I'm going to be able to give children and which ones I'll run out of and won't be able to get,'' Dr. Van Gilder said. ''It's very frustrating and very time consuming.''", "headline": {"main": "Experts Searching for Ways to Fill the Vaccine Gap"}, "abstract": "Article on shortage of American-made vaccines against childhood diseases and impact it is having on pediatricians and parents of children who need them; General Accounting Office is studying why shortages occur and how to prevent them in future; photos (M)", "print_page": "6", "word_count": 1410, "_id": "4fd237d18eb7c8105d7caa31", "snippet": "Within blocks of Dr. Max Van Gilder's bustling pediatric office near Central Park in Manhattan, patients and their parents can readily find bubble bath from France, chocolates from Belgium and fresh melon from South America. But for months now, Dr....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/04/health/experts-searching-for-ways-to-fill-the-vaccine-gap.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "VACCINATION AND IMMUNIZATION"}, {"name": "subject", "value": "SHORTAGES"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Leslie", "lastname": "BERGER"}], "original": "By LESLIE BERGER"}, "document_type": "article", "pub_date": "2002-06-04T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "Everyone knows that creative geniuses are all mad. At least that is what the time-honored notion linking creativity and mental illness holds. Recently, this was underscored by ''A Beautiful Mind,'' the film about the Nobel Prize-winning mathematician Dr. John Forbes Nash Jr., who struggled with schizophrenia. Bedeviled by hallucinations and delusions, Dr. Nash is seen scribbling mathematical formula on his Princeton dorm window and doing pioneering work on game theory in a pub. But in real life, Dr. Nash accomplished his greatest mathematics before his illness really took hold.", "headline": {"main": "Connecting Depression And Artistry", "kicker": "CASES"}, "abstract": "Dr Richard Friedman Cases column describes how treatment with anti-depressants had adverse effect on photographer's view of her creativity; drawing (M)", "print_page": "6", "word_count": 746, "_id": "4fd238e48eb7c8105d7cc354", "snippet": "Everyone knows that creative geniuses are all mad. At least that is what the time-honored notion linking creativity and mental illness holds.    Recently, this was underscored by ''A Beautiful Mind,'' the film about the Nobel Prize-winning...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/04/health/cases-connecting-depression-and-artistry.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MENTAL HEALTH AND DISORDERS"}, {"name": "subject", "value": "DEPRESSION (MENTAL)"}, {"name": "subject", "value": "CREATIVITY"}], "byline": {"person": [{"qualifier": "M.D", "firstname": "Richard", "middlename": "A.", "lastname": "FRIEDMAN", "rank": 1, "role": "reported", "organization": ""}], "original": "By RICHARD A. FRIEDMAN, M.D"}, "document_type": "article", "pub_date": "2002-06-04T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "The number of prescriptions for Celebrex and Vioxx, two heavily advertised medicines for arthritis, is far higher than it should be, based on their apparent narrow benefit over other pain relievers of being safer on the stomach, according to new data from Express Scripts, one of the largest pharmacy benefit management companies. The two new pain relievers have grown controversial because they have not been shown to fight pain better than older drugs like ibuprofen and naproxen, which are available in generic and over-the-counter versions for a fraction of the price.", "headline": {"main": "2 Big-Selling Arthritis Drugs Are Questioned"}, "abstract": "Express Scripts reports number of prescriptions for Celebrex and Vioxx, heavily advertised arthritis drugs, is far higher than it should be, based on their apparent narrow benefit over other pain relievers of being safer on stomach; says some studies show drugs' high price is justified for people at risk of ulcers; notes 74 percent of people taking drugs for first time are not seen to be at risk of ulcers; notes drugs are not more effective than lower-cost pain relievers (M)", "print_page": "16", "word_count": 481, "_id": "4fd269ef8eb7c8105d8213e0", "snippet": "The number of prescriptions for Celebrex and Vioxx, two heavily advertised medicines for arthritis, is far higher than it should be, based on their apparent narrow benefit over other pain relievers of being safer on the stomach, according to new data...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/04/business/2-big-selling-arthritis-drugs-are-questioned.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "EXPRESS SCRIPTS INC"}, {"name": "subject", "value": "CELEBREX (DRUG)"}, {"name": "subject", "value": "ULCERS"}, {"name": "subject", "value": "ADVERTISING"}, {"name": "subject", "value": "STOMACH"}, {"name": "subject", "value": "ARTHRITIS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PRICES (FARES, FEES AND RATES)"}, {"name": "subject", "value": "PAIN-RELIEVING DRUGS"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "VIOXX (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-06-04T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "An editorial in the June 1 issue of The British Medical Journal harshly criticizes a scientific study that the drug company Pharmacia used to promote Celebrex, the arthritis drug that is its best-selling product. Its authors said the study, which concluded that Celebrex, which had $3 billion in sales last year, was safer than other widely used pain relievers because it caused fewer ulcers, had ''serious irregularities.''", "headline": {"main": "Study Finding Celebrex Safer Was Flawed, Journal Says"}, "abstract": "British Medical Journal editorial harshly criticizes scientific study that Pharmacia used to promote Celebrex, arthritis drug that is its best-selling product; authors say study, which concluded that Celebrex was safer than other widely used pain relievers because it caused fewer ulcers, had 'serious irregularities' (S)", "print_page": "12", "word_count": 775, "_id": "4fd21ee78eb7c8105d7a1641", "snippet": "An editorial in the June 1 issue of The British Medical Journal harshly criticizes a scientific study that the drug company Pharmacia used to promote Celebrex, the arthritis drug that is its best-selling product.    Its authors said the study, which...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2002/06/01/us/study-finding-celebrex-safer-was-flawed-journal-says.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "PHARMACIA CORP"}, {"name": "organizations", "value": "BRITISH MEDICAL JOURNAL"}, {"name": "subject", "value": "CELEBREX (DRUG)"}, {"name": "subject", "value": "ARTHRITIS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Melody", "lastname": "PETERSEN"}], "original": "By MELODY PETERSEN"}, "document_type": "article", "pub_date": "2002-06-01T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 4, "offset": 0, "time": 169}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}